181 related articles for article (PubMed ID: 10225773)
1. Membrane apheresis technology: historical perspective and new trends toward bioincompatible systems.
Nosé Y; Yamaji K; Sueoka A; Yamane S
Ther Apher; 1997 Feb; 1(1):5-12. PubMed ID: 10225773
[TBL] [Abstract][Full Text] [Related]
2. Molecular surgery for the treatment of malignant tumors: bioincompatible material apheresis for cancer therapy?
Nosé Y; Ohta K; Miyamoto H; Takaba J; Natsume K
Artif Organs; 2011 Mar; 35(3):308-15. PubMed ID: 21371056
[TBL] [Abstract][Full Text] [Related]
3. Present status of apheresis technologies: Part 1. Membrane plasma separator.
Sueoka A
Ther Apher; 1997 Feb; 1(1):42-8. PubMed ID: 10225780
[TBL] [Abstract][Full Text] [Related]
4. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
5. Membranes in artificial organs.
Schmidt B
Artif Organs; 1996 May; 20(5):375-80. PubMed ID: 8725614
[TBL] [Abstract][Full Text] [Related]
6. [Apheresis Techniques].
Mariano M
G Ital Nefrol; 2017 Sep; 34(5):73-88. PubMed ID: 28963829
[TBL] [Abstract][Full Text] [Related]
7. New insights in end-stage renal disease therapies: from dialysis to apheresis by means of membrane characteristics.
Santoro A
Blood Purif; 2013; 35 Suppl 2():28-9. PubMed ID: 23676833
[No Abstract] [Full Text] [Related]
8. Current devices and new trends in theraputic apheresis.
Murabayashi S
Ther Apher Dial; 2003 Feb; 7(1):36. PubMed ID: 12921112
[No Abstract] [Full Text] [Related]
9. Applications of membrane technologies for therapeutic apheresis.
Sueoka A
Ther Apher; 1998 Nov; 2(4):252-6. PubMed ID: 10227750
[TBL] [Abstract][Full Text] [Related]
10. Apheresis technologies: an international perspective.
Malchesky PS; Bambauer R; Horiuchi T; Kaplan A; Sakurada Y; Samuelsson G
Artif Organs; 1995 Apr; 19(4):315-23. PubMed ID: 7598650
[TBL] [Abstract][Full Text] [Related]
11. Changing scenario of therapeutic apheresis in India in the last 14 years.
Srivastava R; Gupta RC; Khatri PC; Lalchandani A
Ther Apher; 1998 Nov; 2(4):317-9. PubMed ID: 10227765
[TBL] [Abstract][Full Text] [Related]
12. Apheresis: past, present & future.
Robinson EA
Vox Sang; 1994; 67 Suppl 3():151-4. PubMed ID: 7975482
[No Abstract] [Full Text] [Related]
13. Effect of different lipid apheresis methods on plasma polyunsaturated fatty acids.
Schmöcker C; Kassner U; Ostermann AI; Kiesler S; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Atheroscler Suppl; 2017 Nov; 30():193-199. PubMed ID: 29096838
[TBL] [Abstract][Full Text] [Related]
14. Quo vadis haemapheresis. Current developments in haemapheresis.
Borberg H
Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
[TBL] [Abstract][Full Text] [Related]
15. The current status of therapeutic apheresis devices in the United States.
Siami GA; Siami FS
Int J Artif Organs; 2002 Jun; 25(6):499-502. PubMed ID: 12117288
[TBL] [Abstract][Full Text] [Related]
16. The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients.
Baricchi R; Pizzala R; Cacciavillani G; Rivasi P; Tomasi A
Ther Apher; 1998 Aug; 2(3):218-23. PubMed ID: 10227773
[TBL] [Abstract][Full Text] [Related]
17. Status of therapeutic apheresis in Europe.
Gurland HJ
J Clin Apher; 1991; 6(2):93-4. PubMed ID: 1938997
[TBL] [Abstract][Full Text] [Related]
18. Artificial surfaces in apheresis devices: interactions with the complement system.
Malchesky PS
J Clin Apher; 1992; 7(3):145-6. PubMed ID: 1286991
[TBL] [Abstract][Full Text] [Related]
19. Apheresis in the 1990s.
Robinson EA
BMJ; 1993 Sep; 307(6904):578-9. PubMed ID: 8401010
[No Abstract] [Full Text] [Related]
20. Recent advances in therapeutic apheresis.
Bosch T
J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
